Advertisement

Gene Therapy Systems (GTS) Company Profile

15:59 EDT 24th May 2013 | BioPortfolio

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Location

10190 Telesis Court
San Diego
CA
92121
United States of America

Contact

Phone: (858)-457-1919
Fax: 858-623-9494 or 858-558-3617
Email: kmasri@geneTherapysystems.com


News Articles [ 2028 Associated News Articles listed on BioPortfolio]

Gene therapy medicinal products: the first gene therapy product has been approved – where does the future lie?

Is gene therapy close to broad clinical application? Following negative headlines at the end of the 1990s, gene therapy had almost disappeared from the public radar to become an issue almost exclusive...

Sensing gene therapy

Sensory disorders can have a profound effect on health and quality of life—but gene therapy may be coming to the rescue. Gene therapy’s success in treating  blindness disorders –many are in lat...

Stem cell researchers use gene therapy to restore immune systems in 'Bubble Boy' disease

Stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can...

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated...

Targeted gene therapy enhances treatment for Pompe disease

Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of...

UCLA stem cell researchers use gene therapy to restore immune systems in 'bubble babies'

(University of California - Los Angeles Health Sciences) UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" dis...

Using Lipid Nanoparticles To Deliver Genes And Drugs

At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team is using nanotechnology to develop new formulations that can be...

'Gene Therapy for Human Disease: Clinical Advances and Challenges'

(Elsevier) The April issue of Translational Research examines the progress and outlook of gene therapy research, with a specific focus on the clinical applicability of gene therapy today.

PubMed Articles [ 1046 Associated PubMed Articles listed on BioPortfolio]

Microfluidic approaches for gene delivery and gene therapy.

Recent advances in microfluidics have created new and exciting prospects for gene delivery and therapy. The micro-scaled environment within microfluidic systems enables precise control and optimizatio...

Advancement and prospects of tumor gene therapy.

Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical method...

Autoimmunity, recessive diseases, and gene replacement therapy.

Regulatory systems for hypoxia-inducible gene expression in ischemic heart disease gene therapy.

Ischemic heart diseases are caused by narrowed coronary arteries that decrease the blood supply to the myocardium. In the ischemic myocardium, hypoxia-responsive genes are up-regulated by hypoxia-indu...

Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.

Nonviral gene therapy is expected to become a regular treatment for a variety of difficult-to-treat diseases, such as cancer and virus infection. Plasmid DNA, which is used in most nonviral gene deliv...

Clinical Trials [ 1883 Associated Clinical Trials listed on BioPortfolio]

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

RATIONALE: Inserting the gene for adenovirus p53 into a person's tumor may improve the body's ability to fight cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in...

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

RATIONALE: Inserting the gene for p53 into a person's cancer cells may improve the body's ability to fight cancer. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE...

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer

RATIONALE: Inserting the p53 gene into a person's cancer cells may improve the body's ability to fight cancer or make the cancer more sensitive to chemotherapy. Combining chemotherapy with...

Companies [ 2144 Associated Companies listed on BioPortfolio]

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology re...

Neurologix

Neurologix, Inc., a leader in the development of innovative therapies for the brain and central nervous system, utilizes gene therapy and other novel technologies. The central nervous system ("CNS") i...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the righ...

MOLOGEN AG

MOLOGEN is specializing in selected areas of Molecular Medicine. Our areas of competence are gene expression, gene therapy and bioinformatics. We are dedicated to the development of DNA expression and...

More Information about "Gene Therapy Systems (GTS)" on BioPortfolio

We have published hundreds of Gene Therapy Systems (GTS) news stories on BioPortfolio along with dozens of Gene Therapy Systems (GTS) Clinical Trials and PubMed Articles about Gene Therapy Systems (GTS) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gene Therapy Systems (GTS) Companies in our database. You can also find out about relevant Gene Therapy Systems (GTS) Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement